APLS logo

Apellis Pharmaceuticals (APLS) Cash and cash equivalents

annual cash & cash equivalents:

$411.29M+$60.10M(+17.11%)
December 31, 2024

Summary

  • As of today (July 1, 2025), APLS annual cash & cash equivalents is $411.29 million, with the most recent change of +$60.10 million (+17.11%) on December 31, 2024.
  • During the last 3 years, APLS annual cash & cash equivalents has fallen by -$228.90 million (-35.76%).
  • APLS annual cash & cash equivalents is now -35.76% below its all-time high of $640.19 million, reached on December 31, 2021.

Performance

APLS Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSbalance sheet metrics

quarterly cash & cash equivalents:

$358.39M-$52.90M(-12.86%)
March 31, 2025

Summary

  • As of today (July 1, 2025), APLS quarterly cash & cash equivalents is $358.39 million, with the most recent change of -$52.90 million (-12.86%) on March 31, 2025.
  • Over the past year, APLS quarterly cash & cash equivalents has increased by +$32.47 million (+9.96%).
  • APLS quarterly cash & cash equivalents is now -53.16% below its all-time high of $765.08 million, reached on March 31, 2023.

Performance

APLS quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

APLS Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+17.1%+10.0%
3 y3 years-35.8%-43.4%
5 y5 years+16.9%-14.2%

APLS Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-35.8%+17.1%-53.2%+10.0%
5 y5-year-35.8%+17.1%-53.2%+35.0%
alltimeall time-35.8%+8543.5%-53.2%+3472.5%

APLS Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$358.39M(-12.9%)
Dec 2024
$411.29M(+17.1%)
$411.29M(+3.6%)
Sep 2024
-
$396.86M(+10.2%)
Jun 2024
-
$360.09M(+10.5%)
Mar 2024
-
$325.92M(-7.2%)
Dec 2023
$351.19M(-36.4%)
$351.19M(-22.4%)
Sep 2023
-
$452.41M(-26.6%)
Jun 2023
-
$616.26M(-19.5%)
Mar 2023
-
$765.08M(+38.7%)
Dec 2022
$551.80M(-13.8%)
$551.80M(-5.5%)
Sep 2022
-
$584.19M(-3.4%)
Jun 2022
-
$604.49M(-4.6%)
Mar 2022
-
$633.46M(-1.1%)
Dec 2021
$640.19M(+13.2%)
$640.19M(+125.6%)
Sep 2021
-
$283.75M(+4.8%)
Jun 2021
-
$270.76M(+2.0%)
Mar 2021
-
$265.44M(-53.1%)
Dec 2020
$565.78M
$565.78M(+36.1%)
Sep 2020
-
$415.56M(+30.9%)
DateAnnualQuarterly
Jun 2020
-
$317.35M(-24.1%)
Mar 2020
-
$417.88M(+18.7%)
Dec 2019
$351.99M(+99.7%)
$351.99M(-18.9%)
Sep 2019
-
$433.99M(+50.1%)
Jun 2019
-
$289.13M(+0.3%)
Mar 2019
-
$288.25M(+63.5%)
Dec 2018
$176.27M(+0.4%)
$176.27M(-20.1%)
Sep 2018
-
$220.64M(-13.1%)
Jun 2018
-
$253.84M(+66.0%)
Mar 2018
-
$152.93M(-12.9%)
Dec 2017
$175.64M(+606.4%)
$175.64M(+1237.1%)
Sep 2017
-
$13.14M(-74.8%)
Jun 2017
-
$52.19M(+109.9%)
Dec 2016
$24.86M(-30.9%)
$24.86M(-30.9%)
Dec 2015
$36.00M(+164.3%)
$36.00M(+258.9%)
Sep 2015
-
$10.03M(-32.5%)
Jun 2015
-
$14.87M(+9.1%)
Dec 2014
$13.62M(+186.3%)
$13.62M
Dec 2013
$4.76M
-

FAQ

  • What is Apellis Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Apellis Pharmaceuticals quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

What is Apellis Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of APLS is $411.29M

What is the all time high annual cash & cash equivalents for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high annual cash & cash equivalents is $640.19M

What is Apellis Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, APLS annual cash & cash equivalents has changed by +$60.10M (+17.11%)

What is Apellis Pharmaceuticals quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of APLS is $358.39M

What is the all time high quarterly cash & cash equivalents for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high quarterly cash & cash equivalents is $765.08M

What is Apellis Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

Over the past year, APLS quarterly cash & cash equivalents has changed by +$32.47M (+9.96%)
On this page